Gossamer Bio Inc (GOSS) Stock Forecast & Price Target
Gossamer Bio Inc · NASDAQ
$0.19+0.06 (+43.24%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Gossamer Bio Inc, 3 rate it Buy or better, 3 sit at Hold, and 1 rate it Sell or worse, a hold consensus. The target range is very wide, $0.28 to $9.00 (about 32.1x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $2.71 sits 1293% above the current $0.19. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.07 next quarter toward $-0.09 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Hold
Strong Buy00%
Buy343%
Hold343%
Sell114%
Strong Sell00%
Based on 7 analysts giving stock ratings to Gossamer Bio Inc.
As of Jul, 3 of 7 firms rate GOSS a Buy (3 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
GOSS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.07
Range $-0.15 – $-0.04 · 7 analysts · -65% YoY
Next period, 7 analysts expect Gossamer Bio Inc to earn $-0.07 a share (range $-0.15 – $-0.04), versus $-0.21 a year earlier. Full-year consensus is $-0.40, growing to $-0.09 the year after.
REVENUE · NEXT QUARTER
$4.2M
Range $0 – $9.0M · 7 analysts · -69% YoY
Revenue is expected to reach $4.2M (range $0 – $9.0M), -68.8% year-over-year. Full-year consensus is $36.4M, rising to $53.0M next year.
Top analysts covering Gossamer Bio Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GOSS.
#1
Laura Chico
Wedbush · Rank #122
Hold
$1.00+413.3% to target
Overall win rate
40%
+ Follow
#2
Yasmeen Rahimi
Piper Sandler · Rank #152
Buy
$15.00+7600.2% to target
Overall win rate
34%
+ Follow
#3
Greg Harrison
Scotiabank · Rank #177
Buy
$11.00+5546.8% to target
Overall win rate
38%
+ Follow
#4
Patrick R. Trucchio
HC Wainwright & Co. · Rank #203
Buy
$2.00+926.7% to target
Overall win rate
35%
+ Follow
#5
Eliana Merle
Barclays
Sell
$0.28+43.7% to target
Coverage
—
+ Follow
GOSS stock forecast FAQ
What is GOSS's average 12-month price target?+
The 6 analysts with a live target average $2.71 for Gossamer Bio Inc over the next 12 months, ranging from a $9.00 high to a $0.28 low.
Is GOSS stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 7 analyst ratings, 3 are Buy or Strong Buy, 3 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for GOSS?+
The Street-high target is $9.00 (UBS), and the Street-low is $0.28 (Barclays). The average of all 6 active targets is $2.71.
How many Wall Street analysts cover GOSS?+
7 analysts have an active rating on Gossamer Bio Inc, and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering GOSS?+
Among analysts who currently cover GOSS, Laura Chico of Wedbush has the strongest overall Quantellect track record (Rank #122). Their current call is Hold with a $1.00 target.
What is Gossamer Bio Inc's projected EPS for next quarter?+
The consensus estimate is $-0.07 per share (range $-0.15 – $-0.04) across 7 analysts. Full-year EPS is projected at $-0.40, rising to $-0.09 the following year.
How much revenue is Gossamer Bio Inc expected to report next quarter?+
Consensus revenue is $4.2M (range $0 – $9.0M). Full-year revenue is projected at $36.4M, growing to $53.0M next year.
Have analysts been upgrading or downgrading GOSS lately?+
As of Jul, 3 of 7 firms rate GOSS a Buy (3 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GOSS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
